HEATHER SCRIMPSHIRE: Open Payments
NPI 1306484043 · HAMILTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$310 in 15 payments from 7 companies in 2025. Trend: 2023 $340 · 2024 $276 · 2025 $310
Food & beverage: $310
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $142 |
| Novo Nordisk Inc | 4 | $68 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Boston Scientific Corporation | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
Products named: QULIPTA, Ozempic, TRELEGY ELLIPTA, JARDIANCE, VRAYLAR, UBRELVY, WATCHMAN FLX, Rybelsus.
Industry payments across GA — which companies pay providers there.
